Listen

Description

🎯 Tariff Talks: Where Are We Now?

Simon Brown recaps the evolution of Trump-era tariffs, with recent developments around:

Key Insight: Markets are stabilising as the worst-case tariff scenario is dialed back.


💊 Trump vs. Big Pharma

Trump targets high drug prices in the US, pushing for:

Simon’s Take: Healthcare is risky for investors due to constant regulatory pressure — he stays away.


💡 Lewis Group: Surprise Trading Update

Lewis expects a 55–65% EPS increase, sparking:

Verdict: Strong fundamentals, still looks cheap. Simon and analysts are bullish. 📈


🛒 Boxer’s Debut Results

First results since Boxer listed:

Insight: Promising growth but priced in. Shoprite still Simon’s preferred pick. 🏪


🏅 AngloGold Ashanti*: Cash Flow Soars

Highlights from AngloGold’s trading update:

Simon’s Position: Holds the stock, likes the dividends — cautious on expansion. 🪙


🏘️ Calgro M3 vs. Balwin

Property sector comparison:

Bottom Line: Simon owns Calgro, likes both for their contributions to housing. 🏡

Simon Brown

* I hold ungeared positions.

All charts by KoyFin | Get 10% off your order